株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

遺伝子検査の世界市場:2018年〜2022年

Global Genetic Testing Market 2018-2022

発行 TechNavio (Infiniti Research Ltd.) 商品コード 276812
出版日 ページ情報 英文 140 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.58円で換算しております。
Back to Top
遺伝子検査の世界市場:2018年〜2022年 Global Genetic Testing Market 2018-2022
出版日: 2018年02月21日 ページ情報: 英文 140 Pages
概要

Technavioの市場アナリストは、世界の遺伝子検査市場が2022年までに10%以上のCAGRで着実に成長すると予測しています。

当レポートは、製品タイプ(分析装置、消耗品)とアプリケーション(予測・診断検査、出生前・新生児・着床前検査、薬理ゲノムテスト、法医学・親子関係・祖先検査)に基づく世界の遺伝子検査市場の包括的な分析を提供しています。また、地域(米国、APAC、EMEA)に基づく分析も含まれています。

当レポートで扱う項目

  • 2022年の市場規模と成長率
  • 世界の遺伝子検査市場の成長を促進する主な要因
  • 世界の遺伝子検査市場の成長に影響を及ぼす主要な市場動向
  • 市場の成長における課題
  • 世界の遺伝子検査市場における主要ベンダー
  • 世界の遺伝子検査市場におけるベンダーが直面している市場の機会と脅威
  • 南北アメリカ、APAC、EMEAの市場シェアに影響を及ぼすトレンドファクター
  • 世界の遺伝子検査市場のファイブフォース分析の主要結果

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 調査方法

第4章 市場状況

  • 市場のエコシステム
  • 市場特性
  • 市場セグメンテーション分析

第5章 市場規模

  • 市場の定義
  • 市場規模
  • 市場規模および予測

第6章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市場状況

第7章 市場セグメンテーション:アプリケーション別

  • 概要
  • 予測検査・診断検査
  • 出生前・新生児・着床前検査
  • 薬理ゲノミクス検査
  • 法医学・親子関係・祖先検査

第8章 市場セグメンテーション:製品別

  • 概要
  • 比較:製品別
  • 分析装置
  • 消耗品
  • 市場機会:製品別

第9章 顧客情勢

第10章 分割:エンドユーザー別

  • 概要
  • 臨床診断研究所
  • 病院
  • バイオ医薬品企業および研究センター

第11章 地域情勢

  • 地域別セグメンテーション
  • 地域比較
  • 遺伝子検査市場:南北アメリカ
  • 遺伝子検査市場:欧州・中東・アフリカ地域
  • 遺伝子検査市場:アジア太平洋地域
  • 市場機会

第12章 意思決定の枠組み

第13章 成長要因と課題

  • 市場の成長要因
  • 市場の課題

第14章 市場動向

  • コンパニオン診断需要の高まり
  • 現在および将来の遺伝子診断のためのNGSの利用可能性
  • DTC遺伝子検査の採用の拡大

第15章 ベンダー情勢

  • 概要
  • 創造的破壊の状況
  • 競合情勢

第16章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Abbott
  • bioMerieux
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Myriad Genetics
  • QIAGEN
  • Quest Diagnostics

第17章 付録

  • 略語リスト
図表
  • Exhibit 01: Parent market: Global IVD market
  • Exhibit 02: Global IVD market: Segments
  • Exhibit 03: Market characteristics
  • Exhibit 04: Global genetic testing market: Segments
  • Exhibit 05: Market definition: Inclusions and exclusions checklist
  • Exhibit 06: Global genetic testing market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global genetic testing market 2017-2022 ($ millions)
  • Exhibit 09: Global genetic testing market: Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition: Five forces 2017
  • Exhibit 18: Global genetic testing market: Segmentation by application 2017 (% share)
  • Exhibit 19: Global genetic testing market: Segmentation by product 2017-2022 (% share)
  • Exhibit 20: Global genetic testing market: Comparison by product
  • Exhibit 21: Global genetic testing analyzers market 2017-2022 ($ millions)
  • Exhibit 22: Global genetic testing analyzers market: Year-over-year growth 2018-2022 (%)
  • Exhibit 23: Global genetic testing consumables market 2017-2022 ($ millions)
  • Exhibit 24: Global genetic testing consumables market: Year-over-year growth 2018-2022 (%)
  • Exhibit 25: Market opportunity by product
  • Exhibit 26: Customer landscape
  • Exhibit 27: Global genetic testing market: Segmentation by end-user 2017 (% share)
  • Exhibit 28: Global genetic testing market: Segmentation by geography 2017-2022 (% share)
  • Exhibit 29: Regional comparison
  • Exhibit 31: Genetic testing market in Americas 2017-2022 ($ millions)
  • Exhibit 32: Genetic testing market in Americas: Year-over-year growth 2018-2022 (%)
  • Exhibit 33: Top-three countries in Americas
  • Exhibit 34: Genetic testing market in EMEA 2017-2022 ($ millions)
  • Exhibit 35: Genetic testing market in EMEA: Year-over-year growth 2018-2022 (%)
  • Exhibit 36: Top-three countries in EMEA
  • Exhibit 37: Genetic testing market in APAC 2017-2022 ($ millions)
  • Exhibit 38: Genetic testing market in APAC: Year-over-year growth 2018-2022 (%)
  • Exhibit 39: Top-three countries in APAC
  • Exhibit 40: Market opportunity
  • Exhibit 41: Product approvals in few countries and their market impact analysis
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Abbott: Overview
  • Exhibit 48: Abbott: Business segments
  • Exhibit 49: Abbott: Organizational developments
  • Exhibit 50: Abbott: Geographic focus
  • Exhibit 51: Abbott: Segment focus
  • Exhibit 52: Abbott: Key offerings
  • Exhibit 53: Abbott: Key customers
  • Exhibit 54: bioMerieux: Overview
  • Exhibit 55: bioMerieux: Business segments
  • Exhibit 56: bioMerieux: Organizational developments
  • Exhibit 57: bioMerieux: Geographic focus
  • Exhibit 58: bioMerieux: Segment focus
  • Exhibit 59: bioMerieux: Key offerings
  • Exhibit 60: bioMerieux: Key customers
  • Exhibit 61: Bio-Rad Laboratories: Overview
  • Exhibit 62: Bio-Rad Laboratories: Business segments
  • Exhibit 63: Bio-Rad Laboratories: Organizational developments
  • Exhibit 64: Bio-Rad Laboratories: Geographic focus
  • Exhibit 65: Bio-Rad Laboratories: Segment focus
  • Exhibit 66: Bio-Rad Laboratories: Key offerings
  • Exhibit 67: Bio-Rad Laboratories: Key customers
  • Exhibit 68: F. Hoffmann-La Roche: Overview
  • Exhibit 69: F. Hoffmann-La Roche: Business segments
  • Exhibit 70: F. Hoffmann-La Roche: Organizational developments
  • Exhibit 71: F. Hoffmann-La Roche: Geographic focus
  • Exhibit 72: F. Hoffmann-La Roche: Segment focus
  • Exhibit 73: F. Hoffmann-La Roche: Key offerings
  • Exhibit 74: F. Hoffmann-La Roche: Key customers
  • Exhibit 75: Myriad Genetics: Overview
  • Exhibit 76: Myriad Genetics: Business segments
  • Exhibit 77: Myriad Genetics: Organizational developments
  • Exhibit 78: Myriad Genetics: Geographic focus
  • Exhibit 79: Myriad Genetics: Segment focus
  • Exhibit 80: Myriad Genetics: Key offerings
  • Exhibit 81: Myriad Genetics: Key customers
  • Exhibit 82: QIAGEN: Overview
  • Exhibit 83: QIAGEN: Product categories
  • Exhibit 84: QIAGEN: Organizational developments
  • Exhibit 85: QIAGEN: Geographic focus
  • Exhibit 86: QIAGEN: Product categories focus
  • Exhibit 87: QIAGEN: Key offerings
  • Exhibit 88: QIAGEN: Key customers
  • Exhibit 89: Quest Diagnostics: Overview
  • Exhibit 90: Quest Diagnostics: Business segments
  • Exhibit 91: Quest Diagnostics: Organizational developments
  • Exhibit 92: Quest Diagnostics: Geographic focus
  • Exhibit 93: Quest Diagnostics Segment focus
  • Exhibit 94: Quest Diagnostics Key offerings
  • Exhibit 95: Quest Diagnostics: Key customers
目次
Product Code: IRTNTR21575

This industry research report presents a detailed analysis of the genetic testing market by product type (analyzers and consumables) and by application (predictive and diagnostic testing, prenatal, newborn, and pre-implantation testing, pharmacogenomic testing, and forensic, relationship, and ancestry testing). This report also presents an analysis based on geography (the Americas, APAC, and EMEA).

Our market analysts estimate that the market will grow steadily at a CAGR of greater than 10% by 2022.

Key questions answered in the report include:

  • What will the market size and the growth rate be in 2022?
  • What are the key factors driving the global genetic testing market?
  • What are the key market trends impacting the growth of the global genetic testing market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global genetic testing market?
  • What are the market opportunities and threats faced by the vendors in the global genetic testing market?
  • Trending factors influencing the market shares of the Americas, APAC, and EMEA.
  • What are the key outcomes of the five forces analysis of the global genetic testing market?

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: SEGMENTATION BY APPLICATION

  • Overview
  • Predictive and diagnostic testing
  • Prenatal, newborn, and pre-implantation testing
  • Pharmacogenomic testing
  • Forensic, relationship, and ancestry testing

PART 08: SEGMENTATION BY PRODUCT

  • Overview
  • Comparison by product
  • Analyzers
  • Consumables
  • Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: SEGMENTATION BY END-USER

  • Overview
  • Clinical diagnostics laboratories
  • Hospitals
  • Biopharmaceuticals companies and research centers

PART 11: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Genetic testing market in Americas
  • Genetic testing market in EMEA
  • Genetic testing market in APAC
  • Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 14: MARKET TRENDS

  • Growing demand for companion diagnostics
  • Availability of NGS for present and future genetic diagnosis
  • Growing adoption of DTC genetic testing

PART 15: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive landscape

PART 16: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • bioMerieux
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Myriad Genetics
  • QIAGEN
  • Quest Diagnostics

PART 17: APPENDIX

  • List of abbreviations
Back to Top